A patent related to Lialda has been found valid in the first final written decision of a Coalition for Affordable Drugs inter partes review. Decisions from the Patent Trial and Appeal Board on three more patents challenged by the coalition are due this month
Unlock this content.
The content you are trying to view is exclusive to our subscribers.
The model covers court-guided settlements, submissions-led determination of infringement and validity issues, and provides leeway for the court to determine a FRAND rate during negotiations